Advance Search
LI Jing, ZHUANG Yan, XIAO Dingliang, LUO Fangmei. Value of dynamic monitoring of plasma 1, 3-β-D-glucan in evaluating efficiency of drugs for treatment of premature infants with fungal septicemia[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 29-33. DOI: 10.7619/jcmp.202019009
Citation: LI Jing, ZHUANG Yan, XIAO Dingliang, LUO Fangmei. Value of dynamic monitoring of plasma 1, 3-β-D-glucan in evaluating efficiency of drugs for treatment of premature infants with fungal septicemia[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 29-33. DOI: 10.7619/jcmp.202019009
shu

Value of dynamic monitoring of plasma 1, 3-β-D-glucan in evaluating efficiency of drugs for treatment of premature infants with fungal septicemia

  • 1. Department of Pharmacy, 2. The First Department of Neonatology, Hunan Provincial Children's Hospital, Changsha, Hunan, 410000

More Information
  • Received Date: August 05, 2020
    Graphical Abstract
    • Abstract
  • Objective To investigate the value of dynamic monitoring of 1, 3-β-D-glucan(BDG)in evaluating the efficiency of drugs for treatment of premature infants with fungal septicemia. Methods Plasma levels of BDG of 30 premature infants with fungal septicemia in Neonatal Intensive Care Unit(NICU)of Hunan Provincial Children's Hospital from January 2018 to December 2019 were dynamically monitored. Results After antifungal treatment, plasma BDG concentration in 28 cases with effective therapeutic result decreased significantly, among which 8 cases decreased to normal level; 2 dead cases showed progressive increase in plasma BDG, and were in a high level. The duration of antibiotic treatment in children with BDG not decreasing to normal level was significantly longer than that in children with BDG decreasing to normal level(P<0.05). Conclusion Dynamic monitoring of plasma BDG level can evaluate the efficacy of selected antifungal drugs, and also has a certain value in evaluating the prognosis of children with fungal septicemia.
    • FullText(HTML)
    • References (21)
  • ALIAGA S, CLARK R H, LAUGHON M, et al. Changes in the incidence of candidiasis in neonatal intensive care units[J]. Pediatrics, 2014, 133(2): 236-242.
    郑莉莉, 夏红萍, 谢利娟, 等. 早产儿真菌性败血症临床特点及血浆1, 3-β-D葡聚糖检测意义[J]. 中国新生儿科杂志, 2011, 26(5): 296-299.
    陶青松, 张步薇. 血浆(1-3)-β-D葡聚糖检测和真菌培养联合诊断对侵袭性真菌病的诊断价值[J]. 医学检验与临床, 2014, 25(6): 89-91.
    邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019: 532-533.
    李世荣, 王红, 文艳. 血浆(1-3)-β-D-葡聚糖与抗深部白色念珠菌感染药物疗效关系的实验研究[J]. 临床和实验医学杂志, 2007, 6(6): 20-22.
    SENN L, ROBINSON J O, SCHMIDT S, et al. 1, 3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia[J]. Clin Infect Dis, 2008, 46(6): 878-885.
    中华医学会重症医学分会. 重症患者侵袭性真菌感染诊断与治疗指南(2007)[J]. 中华内科杂志, 2007, 46(11): 960-966.
    FRIDKIN S K, KAUFMAN D, EDWARDS J R, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004[J]. Pediatrics, 2006, 117(5): 1680-1687.
    XIA H P, WU H, XIA S W, et al. Invasive Candidiasis in preterm neonates in China: a retrospective study from 11 NICUS during 2009-2011[J]. Pediatr Infect Dis J, 2014, 33(1): 106-109.
    BARTON M, O'BRIEN K, ROBINSON J L, et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls[J]. BMC Infect Dis, 2014, 14: 327-335.
    KELLY M S, BENJAMIN D K JR, SMITH P B. The epidemiology and diagnosis of invasive candidiasis among premature infants[J]. Clin Perinatol, 2015, 42(1): 105-117.
    BENJAMIN D K, STOLL B J, GNTZ M G, et al. Neonatal candidiasis: epidemology, risk factors, and clinical judgment[J]. Pediatrics, 2010, 126(4): e865-e869.
    BENJAMIN D K. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months[J]. Pediatrics, 2006, 117(1): 84-92.
    PAPPAS P G, KAUFFMAN C A, ANDES D R, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America[J]. Clin Infect Dis, 2016, 62(4): e1-e50.
    HEALY C M, BAKER C J. Fluconazole prophylaxis in the neomatal intensive care unit[J]. Pediatr Infect Dis J, 2009, 28(1): 49-57.
    CLEMINSON J, AUSTIN N, MCGUIRE W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants[J]. Cochrane Database Syst Rev, 2015(10): CD003850.
    中华医学会儿科学分会新生儿学组, 中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J]. 中华儿科杂志, 2019, 57(4): 252-257.
    余时娟, 李禄全. 新生儿真菌性败血症23例临床分析[J]. 临床儿科杂志, 2014, 32(9): 816-820.
    YU Y F, DU L Z, YUAN T M, et al. Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients[J]. Am J Perinatol, 2013, 30(7): 589-594.
    ASCHER S B, SMITH P B, WATT K, et al. Antifungal therapy and outcomes in infants with invasive Candida infections[J]. Pediatr Infect Dis J, 2012, 31(5): 439-443.
    温冬华, 刘钰华, 谭坚, 等. 动态监测血浆(1, 3)-β-D-葡聚糖含量对评价侵袭性真菌感染患者药物疗效的价值[J]. 中国医药导报, 2017, 14(35): 110-113

    , 117.
    • Related Articles

  • Cited by

    Periodical cited type(24)

    1. 谌洪江. 体检彩超筛查对甲状腺良恶性病变患者的筛查效能分析. 基层医学论坛. 2025(02): 32-35 .
    2. 沈亚珍，范雯，陈志科. 彩色多普勒超声在浅表软组织肿块诊断中的应用价值. 影像研究与医学应用. 2025(02): 46-48 .
    3. 邓淑敏，朱海侠. 彩超血流参数联合血清STK1水平检测对甲状腺结节性质的鉴别诊断价值. 河南医学研究. 2025(03): 456-459 .
    4. 陈香梅. 超声检查对甲状腺结节的诊断价值研究. 影像研究与医学应用. 2025(03): 125-127 .
    5. 孙琦囡，杜磊，段春华. 高频彩色多普勒超声联合US-FNAC在甲状腺癌诊断中的应用价值. 临床和实验医学杂志. 2024(01): 94-97 .
    6. 李传印，崔志英，韩霞，严梦寒. 超声引导下甲状腺细针穿刺检查在甲状腺肿瘤诊断中的应用价值. 临床研究. 2024(03): 126-129 .
    7. 黄晓萍，贺军. 细针抽吸细胞学联合检测BRAF~(V600E)在甲状腺结节诊断中的应用价值. 中国基层医药. 2024(03): 342-346 .
    8. 谭小娇. 心肌酶谱联合肌钙蛋白检测在甲状腺功能减退症诊断中的意义. 智慧健康. 2024(05): 105-108 .
    9. 孙斌，刘长乐，林福建，曾林胜，黄友贞. 25G型细针对彩超引导下富血供甲状腺结节下穿刺标本满意率的影响. 中国当代医药. 2024(12): 57-60 .
    10. 银园精，廖明珍. 彩色多普勒超声对甲状腺结节的临床诊断价值研究. 影像研究与医学应用. 2024(09): 90-92 .
    11. 卢小利，李洲，周勤鹏，卢淑贞，马友良，杨少胜，高建珠，陆燕虹，单艳丽，何光智. 现场快速评估在超声引导下甲状腺结节细针穿刺中的应用价值研究. 影像研究与医学应用. 2024(15): 173-175+178 .
    12. 王明军，薛源，乔楠，乔乐乐，刘九洲，任宁，程维刚. 超声引导下细针穿刺细胞学、鼠类肉瘤病毒癌基因同源物B V600E基因突变单独及联合检测对甲状腺癌的诊断价值. 癌症进展. 2024(17): 1952-1955 .
    13. 赵婷婷. 二维超声联合彩色多普勒超声在甲状腺结节定性诊断中的应用价值及特征分析. 影像研究与医学应用. 2024(20): 35-37 .
    14. 林立龙. 超声引导下甲状腺细针穿刺细胞学检查对甲状腺结节鉴别诊断价值研究. 现代诊断与治疗. 2024(12): 1859-1861 .
    15. 黄星月，袁霄，夏允，吴蕾，刘悌. 彩色多普勒超声用于鉴别甲状腺结节良恶性的价值. 中国辐射卫生. 2024(05): 590-594 .
    16. 郑小蓓. 彩色多普勒超声与二维超声检查在甲状腺良恶性结节中的诊断价值比较. 医药前沿. 2024(14): 48-50 .
    17. 徐树发. 甲状腺TI-RADS分类结合彩超鉴别诊断甲状腺结节良恶性的分析. 中国医疗器械信息. 2024(22): 11-13+103 .
    18. 黄莉，倪圣霞. 彩色多普勒超声、US-FNA以及两者联合应用在甲状腺癌诊断中的价值和临床意义. 影像技术. 2023(04): 68-72 .
    19. 孙明月，董中琴. 超声剪切波弹性成像定量参数鉴别诊断良恶性甲状腺结节的临床价值. 临床研究. 2023(09): 126-129 .
    20. 徐涛. 彩色多普勒超声对甲状腺良恶性结节的诊断效果. 影像研究与医学应用. 2023(20): 168-170 .
    21. 史文利，王康玮，杜洪. 甲状腺细胞学诊断联合基因检测提高甲状腺乳头状癌诊断率. 广州医科大学学报. 2023(06): 18-22 .
    22. 刘文凤，邵婷. 细针穿刺细胞学检查联合C-TI-RADS在临床鉴别诊断良、恶性甲状腺结节中的应用价值. 影像研究与医学应用. 2023(23): 191-193 .
    23. 崔丽娟. 超声引导下细针穿刺抽吸活检鉴别诊断甲状腺结节良恶性的价值. 实用医技杂志. 2023(10): 702-705 .
    24. 程小莉，赵静，张玲铃. 彩色多普勒超声在甲状腺结节良恶性鉴别中的应用价值. 深圳中西医结合杂志. 2023(23): 80-82 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (401) PDF downloads (10) Cited by(25)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return